Seres Therapeutics MCRB
NASDAQ MCRB
$4.56 -0.01 (-0.22%)
At close: Aug 21, 2026 · 4:00 PM EDT

Seres Therapeutics (MCRB) Change in Inventory (2023 - 2024)

Seres Therapeutics (MCRB) posted Change in Inventory of $10.4 million for Q3 2024, down 5.25% sequentially from $11.0 million in Q2 2024, and down 20.78% YoY from $13.2 million in Q4 2023.

Seres Therapeutics (MCRB) Change in Inventory (2023 - 2024) Analysis & Trends

Seres Therapeutics has reported Change in Inventory for 2 years, with the latest figure at $10.4 million in Q3 2024.

  • Quarterly Change in Inventory fell 20.78% year-over-year to $10.4 million in Q3 2024, while the trailing twelve-month figure through Jun 2025 was $10.4 million (down 78.08% YoY) and the FY2024 annual result came in at $33.8 million, up 13.99% from the prior year.
  • Change in Inventory declined to $10.4 million in Q3 2024 per MCRB's latest filing, from $11.0 million in the prior quarter.
  • Over five years, Change in Inventory peaked at $13.2 million in Q3 2023 and troughed at $5.3 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 27.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 28.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 132.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 47.15 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -280,000.00
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 135.26 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 12.97 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Seres Therapeutics 43.87 Mn 43.87 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 10.45 Mn
Sep 30, 2024 10.45 Mn
Jun 30, 2024 11.02 Mn
Jun 30, 2024 11.02 Mn
Mar 31, 2024 12.33 Mn
Mar 31, 2024 12.33 Mn
Dec 31, 2023 11.12 Mn
Dec 31, 2023 11.12 Mn
Sep 30, 2023 13.19 Mn
Sep 30, 2023 13.19 Mn
Jun 30, 2023 5.34 Mn
Jun 30, 2023 5.34 Mn